Consolidated Statements of Operations - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | |||||
---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2022 |
Sep. 30, 2021 |
|||||
Income Statement [Abstract] | |||||||
Revenue | $ 24,618 | $ 146,120 | $ 50,526 | ||||
Operating expenses | |||||||
Cost of revenue | 20,677 | [1] | 123,845 | [1] | 40,008 | ||
Software development | 702 | [1] | 5,545 | [1] | 1,684 | ||
General and administrative | 12,395 | [1] | 62,510 | [1] | 30,142 | ||
Selling and marketing | 1,380 | [1] | 7,749 | [1] | 2,785 | ||
Total operating expenses | 35,154 | 199,649 | 74,619 | ||||
Loss from operations | (10,536) | (53,529) | (24,093) | ||||
Other non-operating income (expense) | |||||||
Change in fair value of warrant liabilities | 10,909 | 24,225 | (18,331) | ||||
Realized loss from sales of short-term investments | 0 | (2,162) | 0 | ||||
Recapitalization costs attributable to warrant liabilities | 0 | 0 | (1,731) | ||||
Interest income, net | 290 | 3,434 | 460 | ||||
Total other non-operating income (expense) | 11,199 | 25,497 | (19,602) | ||||
Income (loss) before income taxes | 663 | (28,032) | (43,695) | ||||
Income tax benefit | (109) | (772) | (3,643) | ||||
Net income (loss) | $ 772 | $ (27,260) | $ (40,052) | ||||
Net income (loss) per share (Note 11): | |||||||
Basic (in dollars per share) | $ 0.01 | $ (0.38) | $ (0.93) | ||||
Diluted (in dollars per share) | $ 0.01 | $ (0.38) | $ (0.93) | ||||
Weighted-average number of shares outstanding: | |||||||
Basic (in shares) | 69,759,411 | 71,238,103 | 42,883,615 | ||||
Diluted (in shares) | 77,684,893 | 71,238,103 | 42,883,615 | ||||
|
X | ||||||||||
- Definition Recapitalization Costs Attributable To Warrant Liabilities No definition available.
|
X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|